Detalles de la búsqueda
1.
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Hepatology
; 76(1): 220-232, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919289
2.
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
BMC Infect Dis
; 21(1): 413, 2021 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947337
3.
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.
Hepatology
; 66(6): 1814-1825, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28741307
4.
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV).
Viruses
; 16(5)2024 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793565
5.
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.
United European Gastroenterol J
; 12(3): 352-363, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032175
6.
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort.
Int J Infect Dis
; : 107115, 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801968
7.
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort.
Dig Liver Dis
; 55(7): 907-917, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36775720
8.
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination.
Int J Infect Dis
; 129: 266-273, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791877
9.
Obesity and Dysmetabolic Factors among Deceased COVID-19 Adults under 65 Years of Age in Italy: A Retrospective Case-Control Study.
Viruses
; 14(9)2022 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36146787
10.
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort.
Dig Liver Dis
; 53(12): 1603-1609, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33893040
11.
Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.
Mol Biol Cell
; 18(7): 2735-44, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17507655
12.
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort.
Antivir Ther
; 25(2): 73-81, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32242526
13.
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
Hepatol Int
; 14(3): 362-372, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279177
14.
Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin.
FASEB J
; 22(6): 2012-22, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18218920
15.
Immunoregulatory effects of HIV-1 Nef protein.
Biofactors
; 35(2): 169-74, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19449444
16.
HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets.
FASEB J
; 21(10): 2323-34, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17431094
17.
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
PLoS One
; 13(1): e0190803, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29293676
18.
The immunoregulatory effects of HIV-1 Nef on dendritic cells and the pathogenesis of AIDS.
FASEB J
; 20(13): 2198-208, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17077296
19.
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
PLoS One
; 12(2): e0172159, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28245248
20.
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
PLoS One
; 12(10): e0185728, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28977040